MedTrace Logo

The Effect of Thyroid Antibodies on Female Reproductive Function and Pregnancy Outcomes

NCT04952012 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2021-07-07

No results posted yet for this study

Summary

Some women at reproductive age have positive antithyroid antibodies (ATAs). Thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) are the most common ATAs. This study aimed to evaluate the impact of ATAs on maturation of women reproductive system and pregnancy outcomes.

Conditions

  • Thyroiditis, Autoimmune

Interventions

DRUG

LT4

LT4 is used to improve the thyroid function of pregnant women.

Sponsors & Collaborators

  • First People's Hospital of Yuhang

    collaborator UNKNOWN

  • Taizhou Women and Children's Hospital Affiliated to Wenzhou Medical University

    collaborator UNKNOWN

  • Changxing People's Hospital

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2021-11-30
Completion
2022-11-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04952012 on ClinicalTrials.gov